Retatrutide 10mg

Retatrutide (Triple Agonist)

Retatrutide is one of the most advanced next-generation peptides available for scientific research today. It is a precision-engineered "triple agonist" molecule targeting GLP-1, GIP, and Glucagon receptors. Current studies focus on its potential influence on energy expenditure, lipid metabolism, and comprehensive weight regulation models.

Every batch of Retatrutide is produced to pharmaceutical-grade standards. Our rigorous quality control ensures ≥99% purity, validated by independent analysis. Researchers rely on our formulation for its consistency, solubility, and reproducible performance in complex receptor studies.

Product Highlights

Purity: ≥99% (independently verified)

Solubility: Excellent solubility in aqueous buffers

Manufacturing: GMP compliant

Use: Advanced metabolic, lipid, and triple-receptor research

Form: Stable lyophilised powder

Storage Keep sealed and stored dry at 2–8 °C. Once reconstituted, refrigerate and use within 6 weeks.

Disclaimer: For research and laboratory use only. Not for human consumption.